Stock listing

Fennec Pharmaceuticals Inc.

Selected listing: A12A5F · LSX · EUR · DE

Fennec Pharmaceuticals Inc. (LS Exchange: A12A5F), Health Technology. Latest release Sep 17, 2026: Fennec Pharmaceuticals Announces Oral Presentation…

A12A5F:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A12A5F
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LS Exchange
Currency: EUR

Latest news from Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

September 17, 2026

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

August 11, 2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

August 5, 2026

Fennec Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)

June 16, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

June 15, 2026

All Fennec Pharmaceuticals Inc. news →

Events

Replays

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 08:30 AM ET
Watch
Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call
Thu, May 14, 2026 · 08:30 AM ET
Watch
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call
Tue, Mar 24, 2026 · 08:30 AM ET
Watch

Research Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. company profile

View the public company page for Fennec Pharmaceuticals Inc. on 6ix.

Fennec Pharmaceuticals Inc. news

Read company news and market updates connected to Fennec Pharmaceuticals Inc..

Fennec Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Fennec Pharmaceuticals Inc..